CICT's S$3.9b Paragon Acquisition & S$2.5b Asia Square Tower 2 Divestment: A Tactical Portfolio Swap From Leasehold Office To Freehold Orchard Retail-Medical

Based on CICT's media release dated 20 April 2026, CapitaLand Integrated Commercial Trust is swapping a mature Marina Bay leasehold office tower for a freehold Orchard Road retail-and-medical integrated development, at a 90bps yield pick-up. Both transactions are interrelated legs of a disciplined capital redeployment programme and require further regulatory steps: the Paragon acquisition is an interested-party transaction under the SGX Listing Manual and requires unitholder approval at an EGM; completion of both is expected in 2H 2026.

Paragon acquired at agreed property value of S$3,900.0M on a 3.9% net yield (adjusted FY2025 NPI basis). Asia Square Tower 2 (AST2) divested to IOI Marina View Pte. Ltd. (IOI Properties Group, Malaysia) at agreed property value of S$2,476.0M — a 9.9% premium to the S$2,252.0M valuation as at 31 Dec 2025 — on a 3.0% exit yield (post-tax). Pro-forma DPU accretion of 2.1%. Pro-forma aggregate leverage of 39.2%, comfortably below the 50% regulatory limit. Pro-forma CICT portfolio value rises from S$27.0B to S$28.7B, with ~95% of assets still in Singapore. Funding structure: at least S$600M private placement, net AST2 divestment proceeds, and debt top-up. Acquisition fee paid in CICT units to the manager as required for interested-party transactions under the Property Funds Appendix.

The 90bps yield spread is real but the quality of the two yields is different. AST2's 3.0% is a post-tax, settled number on a mature Grade A office with 95.3% committed occupancy as at FY2025, held since the 2017 CapitaLand Commercial Trust era. Paragon's 3.9% is a blended figure — retail at 4.1%, medical/office at 3.4% — on a building last refurbished in 2009. The retail yield is the genuine lift; the medical/office yield sits only 40bps above what CICT is exiting. The swap's income story is therefore more retail-led than the blended headline suggests.

AST2 is on a 99-year lease from March 2008 — roughly 81 years remaining. Paragon is freehold. Valuers price freehold upside explicitly: Paragon's most recent valuations (Knight Frank S$3,895.0M; Cushman & Wakefield S$3,905.0M, both as at 31 Mar 2026) price the asset materially higher than the S$2.9B valuation Paragon Reit held it at when Cuscaden Peak privatised the Reit in April 2025 as a 99-year leasehold property. The tenure conversion alone accounts for a meaningful share of that uplift. CICT is not just buying income; it is buying perpetuity on Orchard Road.

Paragon's medical/office towers — 20,726 sqm / 223,098 sqft NLA — house over 80 multi-disciplinary tenants adjacent to the Mount Elizabeth medical cluster. CICT cites Savills data suggesting fewer than 2,000 medical suites exist in Singapore, with about half locked inside hospital walls. The remaining ~1,000 open-market suites are the supply-constrained category, and Paragon anchors a meaningful share of them. For a REIT whose portfolio has been office- and retail-weighted, adding a structurally scarce medical-tenant layer materially broadens the income-diversification footprint. Tailwinds to monitor: ageing demographics and medical tourism recovery.

Cuscaden Peak's preliminary analysis flags an AEI at Paragon of S$300M or more — the last major refurbishment was in 2009, seventeen years ago. This sits unusually far up the front of the value-creation list for a newly acquired asset. CICT's manager has said it will conduct its own feasibility studies before committing, so the number is indicative, not a commitment. The true economics of this acquisition should be read on a Paragon-plus-AEI basis, not on entry yield alone. A well-sequenced AEI on a freehold Orchard retail asset with 100% committed occupancy and rising prime Orchard rents is the kind of project that tends to compound well over a 5-10 year horizon.

Funding is a three-leg stool: (a) private placement of at least S$600M, (b) net proceeds from the AST2 divestment (S$2,476.0M agreed value), (c) debt top-up. Total acquisition outlay is approximately S$3,919.0M. Pro-forma aggregate leverage settles at 39.2% — consistent with CICT's pre-transaction discipline. The acquisition fee is paid in CICT units, keeping cash in the balance sheet. If the Paragon completion runs ahead of AST2, a bridging loan steps in, to be paid down on AST2 close. A clean, conservative structure that demonstrates capital converting to income at high efficiency.

Post-transaction, CICT anchors Orchard Road through ION Orchard, The Atrium@Orchard, Plaza Singapura, and Paragon — alongside Raffles City Singapore and Funan for the broader downtown footprint. The manager flags prime Orchard retail rents rising quarter-on-quarter with the gap against suburban widening, and 30% of Paragon's rent (by gross income) expiring next year — a rental-reversion window. The competitive set CICT itself flags is honest: Ming Arcade, Tanglin Shopping Centre, Forum The Shopping Mall, voco Orchard Singapore, and HPL House are all scheduled for upgrades or redevelopment in the surrounding catchment. Paragon's 2009 refurbishment vintage means the AEI is not discretionary — it is anchor-tenant depth deepening against a catchment that is about to re-equip itself.

• ▸EGM timing and unitholder approval: Interested-party transaction mechanics require a clean independent financial adviser (IFA) opinion. Watch for EGM notice.
• ▸Luxury spending recovery: CICT itself flagged international luxury spending at 74% of its 2019 peak as a weight on Paragon's performance. Reversion to trend is a tailwind; further post-pandemic drift is a watch-item.
• ▸AEI scope and timing: The S$300M figure is Cuscaden Peak's preliminary analysis. CICT's own feasibility studies will refine both scope and capital intensity; expect an update within 12 months.
• ▸Portfolio value post-completion: S$27.0B → S$28.7B, with ~95% of assets still in Singapore.

Paragon has been added to the PropertyAtlas Asset Directory with a 'PENDING ACQUISITION' status pill; Asia Square Tower 2 has been flagged with a 'PENDING DIVESTMENT' status pill. Both records cite the CICT media release dated 20 April 2026. Records will be reconciled when both transactions complete in 2H 2026.

This is a textbook tactical swap: exit a mature leasehold asset at a premium to book, redeploy into a freehold integrated development with structural defensive attributes and a well-defined AEI runway. The 2.1% DPU accretion is the near-term reward; the freehold premium and medical-suite scarcity are the long-dated positioning plays. The AEI decision (in the S$300M+ range) will be the next material disclosure on Paragon, likely within 12 months. For asset owners and professionals tracking CICT, the cleanest frame is: same portfolio discipline, wider Orchard Road moat, a new income category added.